Bioengineering for COVID-19: Rapid Acceleration of Diagnostics (RADx) at Unprecedented Speed and Scale
Join Beall Applied Innovation and Beckman Laser Institute for a presentation from Bruce Tromberg, director of the National Institute of Biomedical Imaging and Bioengineering. Bruce will discuss how the NIH launched the Rapid Acceleration of Diagnostics initiative in response to the COVID-19 crisis.
The virtual event is hosted by Richard Sudek, executive director at Beall Applied Innovation and chief innovation officer at UCI, and Tom Milner, UCI professor, Surgery and Biomedical Engineering and director at Beckman Laser Institute & Medical Clinic.
Speaker
Bruce Tromberg
Director @The National Institute of Biomedical Imaging and Bioengineering
Dr. Tromberg is the Director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at the National Institutes of Health (NIH) and leads NIBIB’s $500M Rapid Acceleration of Diagnostics (RADx Tech) innovation initiative for increasing SARS-COV-2 testing capacity and performance. Prior to joining NIH in January 2019, he was a professor of Biomedical Engineering and Surgery at the University of California, Irvine (UCI) where he served as director of the Beckman Laser Institute and Medical Clinic (BLIMC) and the Laser Microbeam and Medical Program (LAMMP), an NIH National Biomedical Technology Center. Dr. Tromberg specializes in the development of optics and photonics technologies for biomedical imaging and therapy. He has co-authored more than 450 publications and holds 21 patents in new technology development as well as bench-to-bedside clinical translation, validation and commercialization of biomedical devices.
